20 Years Old, with a 50/50 Chance of Survival: Does High-Risk Leukemia in Young Adults Represent a Failure in Research Priorities?
ST. PETERSBURG, Fla. — While modern pediatric leukemia treatment stands as one of oncology’s greatest triumph stories, a quiet and urgent crisis persists for adolescent and young adult (AYA) patients diagnosed with high-risk acute blood cancers. St. Petersburg-based Jackson Copeland Foundation targets the massive survival disparity gap in AYA acute myeloid leukemia, raising funds for pioneering research with Oct. 30 Anchors & Irons Invitational charity golf tournament in Clearwater.